Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Newby

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Journal of Intellectual Disability Research : JIDR|April 24, 2025
Description of Common Ailments and Nonprescription Medications Found in Medication Reviews for People With Intellectual DisabilityChelsea Felkai, Jamie-Lee Carew, David Newby, et al.
Toxicology and Applied Pharmacology|June 28, 2005
Role of inflammation in cardiopulmonary health effects of PMKen Donaldson, Nicholas Mills, William MacNee, et al.
The British Journal of Radiology|December 11, 2019
Non-invasive imaging of high-risk coronary plaque: the role of computed tomography and positron emission tomographyRong Bing, Krithika Loganath, Philip Adamson, et al.
Pharmacoeconomics - Open|October 23, 2025
The Consistency and Transferability of Economic Evaluations of Disease-Modifying Treatments for Multiple Sclerosis: Analysis of Cost-Effectiveness Assessments from Australia, England, Canada and ScotlandXiang Wang, Feili Zhao, David Newby, et al.
Research in Social & Administrative Pharmacy : RSAP|January 6, 2026
Developing a preliminary, stakeholder-validated service framework for people with intellectual disability: Insights and limitations from a co-design studyChelsea Felkai, Suzanne Neilsen, Joyce Cooper, et al.
Research in Social & Administrative Pharmacy : RSAP|September 22, 2025
Common ailment and non-prescription medication-related problems faced by people with intellectual disability: Findings from medication reviews provided by pharmacistsChelsea Felkai, Jamie-Lee Carew, David Newby, et al.
Future Cardiology|January 22, 2015
Vascular injury and repair: a potential target for cell therapiesAndrew Mitchell, Takeshi Fujisawa, David Newby, et al.
Exploratory Research in Clinical and Social Pharmacy|April 11, 2025
Understanding pharmacists' engagement in sport and exercise medicine, including pharmacist-physiotherapist collaboration: A qualitative study and COM-B analysisAlison D Hooper, Jodie Marquez, Beata Bajorek, et al.
The International Journal of Pharmacy Practice|August 11, 2020
Depression screening in adults by pharmacists in the community: a systematic reviewPeter Miller, David Newby, Emily Walkom, et al.
Exploratory Research in Clinical and Social Pharmacy|September 11, 2024
Medication management issues perceived by pharmacists and disability caregivers while supporting people with disabilityChelsea Felkai, David Newby, Joyce Cooper, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Intellectual Disability Research : JIDR|April 24, 2025
Description of Common Ailments and Nonprescription Medications Found in Medication Reviews for People With Intellectual DisabilityChelsea Felkai, Jamie-Lee Carew, David Newby, et al.
Toxicology and Applied Pharmacology|June 28, 2005
Role of inflammation in cardiopulmonary health effects of PMKen Donaldson, Nicholas Mills, William MacNee, et al.
The British Journal of Radiology|December 11, 2019
Non-invasive imaging of high-risk coronary plaque: the role of computed tomography and positron emission tomographyRong Bing, Krithika Loganath, Philip Adamson, et al.
Pharmacoeconomics - Open|October 23, 2025
The Consistency and Transferability of Economic Evaluations of Disease-Modifying Treatments for Multiple Sclerosis: Analysis of Cost-Effectiveness Assessments from Australia, England, Canada and ScotlandXiang Wang, Feili Zhao, David Newby, et al.
Research in Social & Administrative Pharmacy : RSAP|January 6, 2026
Developing a preliminary, stakeholder-validated service framework for people with intellectual disability: Insights and limitations from a co-design studyChelsea Felkai, Suzanne Neilsen, Joyce Cooper, et al.
Research in Social & Administrative Pharmacy : RSAP|September 22, 2025
Common ailment and non-prescription medication-related problems faced by people with intellectual disability: Findings from medication reviews provided by pharmacistsChelsea Felkai, Jamie-Lee Carew, David Newby, et al.
Future Cardiology|January 22, 2015
Vascular injury and repair: a potential target for cell therapiesAndrew Mitchell, Takeshi Fujisawa, David Newby, et al.
Exploratory Research in Clinical and Social Pharmacy|April 11, 2025
Understanding pharmacists' engagement in sport and exercise medicine, including pharmacist-physiotherapist collaboration: A qualitative study and COM-B analysisAlison D Hooper, Jodie Marquez, Beata Bajorek, et al.
The International Journal of Pharmacy Practice|August 11, 2020
Depression screening in adults by pharmacists in the community: a systematic reviewPeter Miller, David Newby, Emily Walkom, et al.
Exploratory Research in Clinical and Social Pharmacy|September 11, 2024
Medication management issues perceived by pharmacists and disability caregivers while supporting people with disabilityChelsea Felkai, David Newby, Joyce Cooper, et al.
Pageof 5